_id
6919f01c3c536f8df2318582
Ticker
VRCI.LSE
Name
Verici Dx Plc
Exchange
LSE
Address
Avon House, Cardiff, United Kingdom, CF64 2EZ
Country
UK
Sector
Healthcare
Industry
Diagnostics & Research
Currency
GBX
Website
https://vericidx.com
Description
Verici Dx plc, together with its subsidiary, Verici Dx Inc, develops prognostic and diagnostic tests for kidney transplant patients in the United Kingdom and the United States. The company develops Tutivia, a post-transplant diagnostic test focused on acute cellular rejection, including sub-clinical rejection; and Protega, a liquid biopsy to predict the risk of fibrosis and long-term graft failure. It also offers sequencing services for tumor-only, tumor-normal, and germline exomes; whole transcriptome, targeted RNASeq and ncRNAs, and functional binding multicell assay. In addition, the company provides bioinformatics and data science services for exome analysis options; RNA pipeline; multiomic signature discovery, TCR clonotype antigen identification, custom pipeline building, and predictive modeling; and simulation of 100s of drug combinations against multiomic personalized tumor models. It has collaborations with One Lambda Inc. for the commercialization of pre transplant risk assessment (PTRA), a pre-transplant prognosis test for the risk of early acute rejection; The Westmead Institute for Medical Research to determine the factors contributing to graft loss in organ transplants; and FBB Biomed, Inc., which provides research-use-only tests for clinicians seeking insights into neurologic diseases, such as multiple sclerosis and long COVID. Verici Dx plc was incorporated in 2020 and is based in Cardiff, the United Kingdom.
Last Close
7750
Volume
1544527
Current Price
7500
Change
-3.2258064516129057
Last Updated
2025-12-30T11:44:07.594Z
Image
https://logo.clearbit.com/vericidx.com
Ipo Date
-
Market Cap
11728805
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
-
Sentiment Sources
0
Rating
4
Strong Buy
0
Buy
1
Hold
0
Sell
0
Strong Sell
0
Current Quarter
2025-06-30
Revenue
1475290
Cost Of Revenue
502817
Gross Profit
1561000
Operating Expenses
3292218
Operating Income
-2319745
Interest Expense
6940
Pretax Income
-2382982
Net Income
-2382982
Eps
-0.00982504946906483
Dividends Per Share
-
Shares Outstanding
1513394127
Income Tax Expense
-
EBITDA
-2800000
Operating Margin
-157.23993248784984
Total Other Income Expense Net
-63237
Cash
467000
Short Term Investments
-
Receivables
792000
Inventories
-
Total Current Assets
1749000
Property Plant Equipment
652000
Total Assets
4545000
Payables
971000
Short Term Debt
245623
Long Term Debt
-
Total Liabilities
2063000
Equity
2482000
Bs_currency_symbol
USD
Depreciation
300000
Change In Working Capital
-657055
Cash From Operations
-2706883
Capital Expenditures
0
Cash From Investing
-47813
Cash From Financing
-68636
Net Change In Cash
-2901786
Cf_currency_symbol
-
PE
-
PB
732901.3174858984
ROE
-96.0105560032232
ROA
-52.430847084708475
FCF
-2706883
Fcf Percent
-1.8348141721288695
Piotroski FScore
0
Health Score
22
Deep Value Investing Score
2.5
Defensive Investing Score
6
Dividend Investing Score
1.5
Economic Moat Investing Score
3.8
Garp Investing Score
1.5
Growth Investing Score
0.5
Momentum Investing Score
3
Net Net Investing Score
2.5
Quality Investing Score
2.5
Value Investing Score
3
Quarters > 0 > quarter
2025-06-30
Quarters > 0 > income Statement > revenue
1475290
Quarters > 0 > income Statement > cost Of Revenue
502817
Quarters > 0 > income Statement > gross Profit
1561000
Quarters > 0 > income Statement > operating Expenses
3292218
Quarters > 0 > income Statement > operating Income
-2319745
Quarters > 0 > income Statement > interest Expense
6940
Quarters > 0 > income Statement > pretax Income
-2382982
Quarters > 0 > income Statement > net Income
-2382982
Quarters > 0 > income Statement > eps
-0.00982504946906483
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
242541476
Quarters > 0 > income Statement > income Tax Expense
-
Quarters > 0 > income Statement > EBITDA
-2800000
Quarters > 0 > income Statement > operating Margin
-157.23993248784984
Quarters > 0 > income Statement > total Other Income Expense Net
-63237
Quarters > 0 > income Statement > currency_symbol
-
Quarters > 0 > balance Sheet > cash
467000
Quarters > 0 > balance Sheet > short Term Investments
-
Quarters > 0 > balance Sheet > receivables
792000
Quarters > 0 > balance Sheet > inventories
-
Quarters > 0 > balance Sheet > total Current Assets
1749000
Quarters > 0 > balance Sheet > property Plant Equipment
652000
Quarters > 0 > balance Sheet > total Assets
4545000
Quarters > 0 > balance Sheet > payables
971000
Quarters > 0 > balance Sheet > short Term Debt
245623
Quarters > 0 > balance Sheet > long Term Debt
-
Quarters > 0 > balance Sheet > total Liabilities
2063000
Quarters > 0 > balance Sheet > equity
2482000
Quarters > 0 > balance Sheet > currency_symbol
USD
Quarters > 0 > cash Flow > net Income
-3090000
Quarters > 0 > cash Flow > depreciation
300000
Quarters > 0 > cash Flow > change In Working Capital
-657055
Quarters > 0 > cash Flow > cash From Operations
-2706883
Quarters > 0 > cash Flow > capital Expenditures
0
Quarters > 0 > cash Flow > cash From Investing
-47813
Quarters > 0 > cash Flow > cash From Financing
-68636
Quarters > 0 > cash Flow > net Change In Cash
-2901786
Quarters > 0 > cash Flow > currency_symbol
-
Quarters > 0 > ratios > PE
-0.00982504946906483
Quarters > 0 > ratios > PB
732901.3174858984
Quarters > 0 > ratios > ROE
-96.0105560032232
Quarters > 0 > ratios > ROA
-52.430847084708475
Quarters > 0 > ratios > FCF
-2706883
Quarters > 0 > ratios > Piotroski FScore
0
Quarters > 0 > ratios > fcf Percent
-1.8348141721288695
Quarters > 0 > health Score
22
Quarters > 1 > quarter
2024-12-31
Quarters > 1 > income Statement > revenue
-
Quarters > 1 > income Statement > cost Of Revenue
-
Quarters > 1 > income Statement > gross Profit
-
Quarters > 1 > income Statement > operating Expenses
4653000
Quarters > 1 > income Statement > operating Income
-4653000
Quarters > 1 > income Statement > interest Expense
-
Quarters > 1 > income Statement > pretax Income
-4526000
Quarters > 1 > income Statement > net Income
-4526000
Quarters > 1 > income Statement > eps
-0.018648118762658015
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
242705447
Quarters > 1 > income Statement > income Tax Expense
-
Quarters > 1 > income Statement > EBITDA
-4305000
Quarters > 1 > income Statement > operating Margin
-
Quarters > 1 > income Statement > total Other Income Expense Net
127000
Quarters > 1 > income Statement > currency_symbol
-
Quarters > 1 > balance Sheet > cash
4061000
Quarters > 1 > balance Sheet > short Term Investments
-
Quarters > 1 > balance Sheet > receivables
0
Quarters > 1 > balance Sheet > inventories
-
Quarters > 1 > balance Sheet > total Current Assets
4565000
Quarters > 1 > balance Sheet > property Plant Equipment
858000
Quarters > 1 > balance Sheet > total Assets
7492000
Quarters > 1 > balance Sheet > payables
658000
Quarters > 1 > balance Sheet > short Term Debt
182000
Quarters > 1 > balance Sheet > long Term Debt
-
Quarters > 1 > balance Sheet > total Liabilities
2227000
Quarters > 1 > balance Sheet > equity
5265000
Quarters > 1 > balance Sheet > currency_symbol
USD
Quarters > 1 > cash Flow > net Income
-4526000
Quarters > 1 > cash Flow > depreciation
313000
Quarters > 1 > cash Flow > change In Working Capital
1430000
Quarters > 1 > cash Flow > cash From Operations
-2843000
Quarters > 1 > cash Flow > capital Expenditures
3000
Quarters > 1 > cash Flow > cash From Investing
156000
Quarters > 1 > cash Flow > cash From Financing
-214000
Quarters > 1 > cash Flow > net Change In Cash
-7015000
Quarters > 1 > cash Flow > currency_symbol
-
Quarters > 1 > ratios > PE
-0.018648118762658015
Quarters > 1 > ratios > PB
345734.25498575496
Quarters > 1 > ratios > ROE
-85.9639126305793
Quarters > 1 > ratios > ROA
-60.41110517885745
Quarters > 1 > ratios > FCF
-2846000
Quarters > 1 > ratios > Piotroski FScore
1
Quarters > 1 > ratios > fcf Percent
-
Quarters > 1 > health Score
35
Quarters > 2 > quarter
2024-06-30
Quarters > 2 > income Statement > revenue
3339000
Quarters > 2 > income Statement > cost Of Revenue
-
Quarters > 2 > income Statement > gross Profit
3339000
Quarters > 2 > income Statement > operating Expenses
4792000
Quarters > 2 > income Statement > operating Income
-1453000
Quarters > 2 > income Statement > interest Expense
-
Quarters > 2 > income Statement > pretax Income
-1348000
Quarters > 2 > income Statement > net Income
-1348000
Quarters > 2 > income Statement > eps
-0.00605596165914966
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
222590577
Quarters > 2 > income Statement > income Tax Expense
-
Quarters > 2 > income Statement > EBITDA
-1065000
Quarters > 2 > income Statement > operating Margin
-43.51602276130578
Quarters > 2 > income Statement > total Other Income Expense Net
105000
Quarters > 2 > income Statement > currency_symbol
-
Quarters > 2 > balance Sheet > cash
7015000
Quarters > 2 > balance Sheet > short Term Investments
-
Quarters > 2 > balance Sheet > receivables
1500000
Quarters > 2 > balance Sheet > inventories
386000
Quarters > 2 > balance Sheet > total Current Assets
8949000
Quarters > 2 > balance Sheet > property Plant Equipment
1073000
Quarters > 2 > balance Sheet > total Assets
12106000
Quarters > 2 > balance Sheet > payables
661000
Quarters > 2 > balance Sheet > short Term Debt
184000
Quarters > 2 > balance Sheet > long Term Debt
-
Quarters > 2 > balance Sheet > total Liabilities
2245000
Quarters > 2 > balance Sheet > equity
9861000
Quarters > 2 > balance Sheet > currency_symbol
USD
Quarters > 2 > cash Flow > net Income
-1348000
Quarters > 2 > cash Flow > depreciation
388000
Quarters > 2 > cash Flow > change In Working Capital
-590000
Quarters > 2 > cash Flow > cash From Operations
-3177000
Quarters > 2 > cash Flow > capital Expenditures
14000
Quarters > 2 > cash Flow > cash From Investing
-95000
Quarters > 2 > cash Flow > cash From Financing
7536000
Quarters > 2 > cash Flow > net Change In Cash
7015000
Quarters > 2 > cash Flow > currency_symbol
-
Quarters > 2 > ratios > PE
-0.00605596165914966
Quarters > 2 > ratios > PB
169296.1492242166
Quarters > 2 > ratios > ROE
-13.670013183247134
Quarters > 2 > ratios > ROA
-11.134974392863043
Quarters > 2 > ratios > FCF
-3191000
Quarters > 2 > ratios > Piotroski FScore
0
Quarters > 2 > ratios > fcf Percent
-0.955675351901767
Quarters > 2 > health Score
26
Quarters > 3 > quarter
2024-03-31
Quarters > 3 > income Statement > revenue
1669500
Quarters > 3 > income Statement > cost Of Revenue
-
Quarters > 3 > income Statement > gross Profit
1669500
Quarters > 3 > income Statement > operating Expenses
2396000
Quarters > 3 > income Statement > operating Income
-726500
Quarters > 3 > income Statement > interest Expense
-
Quarters > 3 > income Statement > pretax Income
-674000
Quarters > 3 > income Statement > net Income
-674000
Quarters > 3 > income Statement > eps
-0.00302798082957483
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
222590577
Quarters > 3 > income Statement > income Tax Expense
-
Quarters > 3 > income Statement > EBITDA
-532500
Quarters > 3 > income Statement > operating Margin
-43.51602276130578
Quarters > 3 > income Statement > total Other Income Expense Net
52500
Quarters > 3 > income Statement > currency_symbol
-
Quarters > 3 > balance Sheet > cash
7015000
Quarters > 3 > balance Sheet > short Term Investments
-
Quarters > 3 > balance Sheet > receivables
1500000
Quarters > 3 > balance Sheet > inventories
386000
Quarters > 3 > balance Sheet > total Current Assets
8949000
Quarters > 3 > balance Sheet > property Plant Equipment
1073000
Quarters > 3 > balance Sheet > total Assets
12106000
Quarters > 3 > balance Sheet > payables
661000
Quarters > 3 > balance Sheet > short Term Debt
184000
Quarters > 3 > balance Sheet > long Term Debt
-
Quarters > 3 > balance Sheet > total Liabilities
2245000
Quarters > 3 > balance Sheet > equity
9861000
Quarters > 3 > balance Sheet > currency_symbol
-
Quarters > 3 > cash Flow > net Income
-674000
Quarters > 3 > cash Flow > depreciation
194000
Quarters > 3 > cash Flow > change In Working Capital
-295000
Quarters > 3 > cash Flow > cash From Operations
-1588500
Quarters > 3 > cash Flow > capital Expenditures
7000
Quarters > 3 > cash Flow > cash From Investing
-
Quarters > 3 > cash Flow > cash From Financing
3768000
Quarters > 3 > cash Flow > net Change In Cash
2185000
Quarters > 3 > cash Flow > currency_symbol
-
Quarters > 3 > ratios > PE
-0.00302798082957483
Quarters > 3 > ratios > PB
169296.1492242166
Quarters > 3 > ratios > ROE
-6.835006591623567
Quarters > 3 > ratios > ROA
-5.567487196431522
Quarters > 3 > ratios > FCF
-1595500
Quarters > 3 > ratios > Piotroski FScore
0
Quarters > 3 > ratios > fcf Percent
-0.955675351901767
Quarters > 3 > health Score
26
Annuals > 0 > quarter
2024-12-31
Annuals > 0 > income Statement > revenue
3339000
Annuals > 0 > income Statement > cost Of Revenue
-
Annuals > 0 > income Statement > gross Profit
3339000
Annuals > 0 > income Statement > operating Expenses
9445000
Annuals > 0 > income Statement > operating Income
-6106000
Annuals > 0 > income Statement > interest Expense
22000
Annuals > 0 > income Statement > pretax Income
-5874000
Annuals > 0 > income Statement > net Income
-5874000
Annuals > 0 > income Statement > eps
-0.025248442698921493
Annuals > 0 > income Statement > dividends Per Share
-
Annuals > 0 > income Statement > shares Outstanding
232648012
Annuals > 0 > income Statement > income Tax Expense
-
Annuals > 0 > income Statement > EBITDA
-5151000
Annuals > 0 > income Statement > operating Margin
-182.869122491764
Annuals > 0 > income Statement > total Other Income Expense Net
232000
Annuals > 0 > income Statement > currency_symbol
USD
Annuals > 0 > balance Sheet > cash
4061000
Annuals > 0 > balance Sheet > short Term Investments
-
Annuals > 0 > balance Sheet > receivables
0
Annuals > 0 > balance Sheet > inventories
-
Annuals > 0 > balance Sheet > total Current Assets
4565000
Annuals > 0 > balance Sheet > property Plant Equipment
858000
Annuals > 0 > balance Sheet > total Assets
7492000
Annuals > 0 > balance Sheet > payables
658000
Annuals > 0 > balance Sheet > short Term Debt
182000
Annuals > 0 > balance Sheet > long Term Debt
-
Annuals > 0 > balance Sheet > total Liabilities
2227000
Annuals > 0 > balance Sheet > equity
5265000
Annuals > 0 > balance Sheet > currency_symbol
USD
Annuals > 0 > cash Flow > net Income
-5874000
Annuals > 0 > cash Flow > depreciation
701000
Annuals > 0 > cash Flow > change In Working Capital
-650000
Annuals > 0 > cash Flow > cash From Operations
-6020000
Annuals > 0 > cash Flow > capital Expenditures
193000
Annuals > 0 > cash Flow > cash From Investing
61000
Annuals > 0 > cash Flow > cash From Financing
7322000
Annuals > 0 > cash Flow > net Change In Cash
1416000
Annuals > 0 > cash Flow > currency_symbol
USD
Annuals > 0 > ratios > PE
-0.025248442698921493
Annuals > 0 > ratios > PB
31.152297903133903
Annuals > 0 > ratios > ROE
-111.56695156695157
Annuals > 0 > ratios > ROA
-78.40363053924186
Annuals > 0 > ratios > FCF
-6213000
Annuals > 0 > ratios > Piotroski FScore
1
Annuals > 0 > ratios > fcf Percent
-1.8607367475292003
Annuals > 0 > health Score
27
Annuals > 1 > quarter
2023-12-31
Annuals > 1 > income Statement > revenue
1013000
Annuals > 1 > income Statement > cost Of Revenue
1
Annuals > 1 > income Statement > gross Profit
1013000
Annuals > 1 > income Statement > operating Expenses
9880000
Annuals > 1 > income Statement > operating Income
-8867000
Annuals > 1 > income Statement > interest Expense
29000
Annuals > 1 > income Statement > pretax Income
-8734000
Annuals > 1 > income Statement > net Income
-8734000
Annuals > 1 > income Statement > eps
-0.05128017095190857
Annuals > 1 > income Statement > dividends Per Share
-
Annuals > 1 > income Statement > shares Outstanding
170319245
Annuals > 1 > income Statement > income Tax Expense
162000
Annuals > 1 > income Statement > EBITDA
-7876000
Annuals > 1 > income Statement > operating Margin
-875.3208292201382
Annuals > 1 > income Statement > total Other Income Expense Net
133000
Annuals > 1 > income Statement > currency_symbol
USD
Annuals > 1 > balance Sheet > cash
2645000
Annuals > 1 > balance Sheet > short Term Investments
-
Annuals > 1 > balance Sheet > receivables
1100000
Annuals > 1 > balance Sheet > inventories
-87001
Annuals > 1 > balance Sheet > total Current Assets
3989000
Annuals > 1 > balance Sheet > property Plant Equipment
1363000
Annuals > 1 > balance Sheet > total Assets
7443000
Annuals > 1 > balance Sheet > payables
475000
Annuals > 1 > balance Sheet > short Term Debt
163000
Annuals > 1 > balance Sheet > long Term Debt
-
Annuals > 1 > balance Sheet > total Liabilities
3885000
Annuals > 1 > balance Sheet > equity
3558000
Annuals > 1 > balance Sheet > currency_symbol
USD
Annuals > 1 > cash Flow > net Income
-8734000
Annuals > 1 > cash Flow > depreciation
829000
Annuals > 1 > cash Flow > change In Working Capital
425000
Annuals > 1 > cash Flow > cash From Operations
-7160000
Annuals > 1 > cash Flow > capital Expenditures
231000
Annuals > 1 > cash Flow > cash From Investing
-231000
Annuals > 1 > cash Flow > cash From Financing
-27000
Annuals > 1 > cash Flow > net Change In Cash
-7160000
Annuals > 1 > cash Flow > currency_symbol
USD
Annuals > 1 > ratios > PE
-0.05128017095190857
Annuals > 1 > ratios > PB
33.747911108768974
Annuals > 1 > ratios > ROE
-245.47498594716131
Annuals > 1 > ratios > ROA
-117.34515652290742
Annuals > 1 > ratios > FCF
-7391000
Annuals > 1 > ratios > Piotroski FScore
0
Annuals > 1 > ratios > fcf Percent
-7.296150049358341
Annuals > 1 > health Score
16
Annuals > 2 > quarter
2022-12-31
Annuals > 2 > income Statement > revenue
0
Annuals > 2 > income Statement > cost Of Revenue
-
Annuals > 2 > income Statement > gross Profit
-
Annuals > 2 > income Statement > operating Expenses
11455000
Annuals > 2 > income Statement > operating Income
-11455000
Annuals > 2 > income Statement > interest Expense
5000
Annuals > 2 > income Statement > pretax Income
-11407000
Annuals > 2 > income Statement > net Income
-11359000
Annuals > 2 > income Statement > eps
-0.06898132587634613
Annuals > 2 > income Statement > dividends Per Share
-
Annuals > 2 > income Statement > shares Outstanding
164667754
Annuals > 2 > income Statement > income Tax Expense
-48000
Annuals > 2 > income Statement > EBITDA
-10497000
Annuals > 2 > income Statement > operating Margin
-
Annuals > 2 > income Statement > total Other Income Expense Net
48000
Annuals > 2 > income Statement > currency_symbol
USD
Annuals > 2 > balance Sheet > cash
9805000
Annuals > 2 > balance Sheet > short Term Investments
-
Annuals > 2 > balance Sheet > receivables
520000
Annuals > 2 > balance Sheet > inventories
-
Annuals > 2 > balance Sheet > total Current Assets
10325000
Annuals > 2 > balance Sheet > property Plant Equipment
2010000
Annuals > 2 > balance Sheet > total Assets
14305000
Annuals > 2 > balance Sheet > payables
960000
Annuals > 2 > balance Sheet > short Term Debt
156000
Annuals > 2 > balance Sheet > long Term Debt
-
Annuals > 2 > balance Sheet > total Liabilities
2796000
Annuals > 2 > balance Sheet > equity
11509000
Annuals > 2 > balance Sheet > currency_symbol
USD
Annuals > 2 > cash Flow > net Income
-11407000
Annuals > 2 > cash Flow > depreciation
640000
Annuals > 2 > cash Flow > change In Working Capital
429000
Annuals > 2 > cash Flow > cash From Operations
-10068000
Annuals > 2 > cash Flow > capital Expenditures
1308000
Annuals > 2 > cash Flow > cash From Investing
-1308000
Annuals > 2 > cash Flow > cash From Financing
12674000
Annuals > 2 > cash Flow > net Change In Cash
-535000
Annuals > 2 > cash Flow > currency_symbol
USD
Annuals > 2 > ratios > PE
-0.06898132587634613
Annuals > 2 > ratios > PB
10.08695512816057
Annuals > 2 > ratios > ROE
-98.69667216960639
Annuals > 2 > ratios > ROA
-79.40580216707444
Annuals > 2 > ratios > FCF
-11376000
Annuals > 2 > ratios > Piotroski FScore
0
Annuals > 2 > ratios > fcf Percent
-
Annuals > 2 > health Score
26
Annuals > 3 > quarter
2021-12-31
Annuals > 3 > income Statement > revenue
0
Annuals > 3 > income Statement > cost Of Revenue
-
Annuals > 3 > income Statement > gross Profit
-
Annuals > 3 > income Statement > operating Expenses
8329000
Annuals > 3 > income Statement > operating Income
-8329829
Annuals > 3 > income Statement > interest Expense
0
Annuals > 3 > income Statement > pretax Income
-8329829
Annuals > 3 > income Statement > net Income
-8329829
Annuals > 3 > income Statement > eps
-0.058765131167876336
Annuals > 3 > income Statement > dividends Per Share
-
Annuals > 3 > income Statement > shares Outstanding
141747816
Annuals > 3 > income Statement > income Tax Expense
-740000
Annuals > 3 > income Statement > EBITDA
-7151000
Annuals > 3 > income Statement > operating Margin
-
Annuals > 3 > income Statement > total Other Income Expense Net
-829
Annuals > 3 > income Statement > currency_symbol
USD
Annuals > 3 > balance Sheet > cash
10339788
Annuals > 3 > balance Sheet > short Term Investments
-
Annuals > 3 > balance Sheet > receivables
249656
Annuals > 3 > balance Sheet > inventories
-
Annuals > 3 > balance Sheet > total Current Assets
10995635
Annuals > 3 > balance Sheet > property Plant Equipment
785736
Annuals > 3 > balance Sheet > total Assets
13788994
Annuals > 3 > balance Sheet > payables
160000
Annuals > 3 > balance Sheet > short Term Debt
-
Annuals > 3 > balance Sheet > long Term Debt
-
Annuals > 3 > balance Sheet > total Liabilities
1804109
Annuals > 3 > balance Sheet > equity
11984885
Annuals > 3 > balance Sheet > currency_symbol
USD
Annuals > 3 > cash Flow > net Income
-8329829
Annuals > 3 > cash Flow > depreciation
437756
Annuals > 3 > cash Flow > change In Working Capital
814800
Annuals > 3 > cash Flow > cash From Operations
-6336444
Annuals > 3 > cash Flow > capital Expenditures
965859
Annuals > 3 > cash Flow > cash From Investing
-965859
Annuals > 3 > cash Flow > cash From Financing
-73548
Annuals > 3 > cash Flow > net Change In Cash
-7411299
Annuals > 3 > cash Flow > currency_symbol
USD
Annuals > 3 > ratios > PE
-0.058765131167876336
Annuals > 3 > ratios > PB
8.338186831162751
Annuals > 3 > ratios > ROE
-69.50278621780684
Annuals > 3 > ratios > ROA
-60.40925828236635
Annuals > 3 > ratios > FCF
-7302303
Annuals > 3 > ratios > Piotroski FScore
0
Annuals > 3 > ratios > fcf Percent
-
Annuals > 3 > health Score
26
Valuation > metrics > PE
-0.00982504946906483
Valuation > metrics > PB
732901.3174858984
Valuation > final Score
20
Valuation > verdict
24429943.9% Overvalued
Profitability > metrics > ROE
-96.0105560032232
Profitability > metrics > ROA
-136.24825614636936
Profitability > metrics > Net Margin
-1.6152634397304937
Profitability > final Score
0
Profitability > verdict
Weak
Risk > metrics > Debt Equity
0.8311845286059629
Risk > metrics > Interest Coverage
-334.257204610951
Risk > final Score
-1289
Risk > verdict
High
Liquidity > metrics > Current Ratio
1.437585842122005
Liquidity > metrics > Quick Ratio
1.437585842122005
Liquidity > final Score
86
Liquidity > verdict
Great
Prev Valuations > 0
20
Prev Valuations > 1
20
Prev Valuations > 2
20
Prev Profitabilities > 0
15
Prev Profitabilities > 1
0
Prev Profitabilities > 2
0
Prev Risks > 0
-24
Prev Risks > 1
39
Prev Risks > 2
39
Prev Liquidities > 0
100
Prev Liquidities > 1
100
Prev Liquidities > 2
100
Updated At
2026-01-20T23:04:48.320Z
Earnings History > 0 > period
2025-06-30
Earnings History > 0 > report Date
2025-07-07
Earnings History > 0 > date
2025-06-30
Earnings History > 0 > before After Market
-
Earnings History > 0 > currency
-
Earnings History > 0 > eps Actual
-0.02
Earnings History > 0 > eps Estimate
0
Earnings History > 0 > eps Difference
-0.02
Earnings History > 0 > surprise Percent
-
Earnings History > 1 > period
2025-03-31
Earnings History > 1 > report Date
2025-06-30
Earnings History > 1 > date
2025-03-31
Earnings History > 1 > before After Market
-
Earnings History > 1 > currency
-
Earnings History > 1 > eps Actual
-0.02
Earnings History > 1 > eps Estimate
0
Earnings History > 1 > eps Difference
-0.02
Earnings History > 1 > surprise Percent
-
Earnings History > 2 > period
2024-06-30
Earnings History > 2 > report Date
2024-07-15
Earnings History > 2 > date
2024-06-30
Earnings History > 2 > before After Market
-
Earnings History > 2 > currency
-
Earnings History > 2 > eps Actual
-0.01
Earnings History > 2 > eps Estimate
0
Earnings History > 2 > eps Difference
-0.01
Earnings History > 2 > surprise Percent
-
Verici Dx plc, together with its subsidiary, Verici Dx Inc, develops prognostic and diagnostic tests for kidney transplant patients in the United Kingdom and the United States. The company develops Tutivia, a post-transplant diagnostic test focused on acute cellular rejection, including sub-clinical rejection; and Protega, a liquid biopsy to predict the risk of fibrosis and long-term graft failure. It also offers sequencing services for tumor-only, tumor-normal, and germline exomes; whole transcriptome, targeted RNASeq and ncRNAs, and functional binding multicell assay. In addition, the company provides bioinformatics and data science services for exome analysis options; RNA pipeline; multiomic signature discovery, TCR clonotype antigen identification, custom pipeline building, and predictive modeling; and simulation of 100s of drug combinations against multiomic personalized tumor models. It has collaborations with One Lambda Inc. for the commercialization of pre transplant risk assessment (PTRA), a pre-transplant prognosis test for the risk of early acute rejection; The Westmead Institute for Medical Research to determine the factors contributing to graft loss in organ transplants; and FBB Biomed, Inc., which provides research-use-only tests for clinicians seeking insights into neurologic diseases, such as multiple sclerosis and long COVID. Verici Dx plc was incorporated in 2020 and is based in Cardiff, the United Kingdom.
Stock Price
GBp 0.00
decrease compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/AVerici Dx Share Price. VRCI - Stock Quote, Charts, Trade History, Share Chat, VRCI Values. Verici Dx Plc Ord Gbp0.001 London South East
Read more →(Last Updated 2025-06-30)
Rating:
BUY
$
Analyst Picks
Strong Buy
0
Buy
1
Hold
0
Sell
0
Strong Sell
0
(Last Updated 2025-06-30)
Health Score
Price to Book Ratio (P/B)
-
Very High
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very Low
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
Free Cash Flow - Revenue % (FCF)
-
Very Low
Low ≤ 5%
High ≥ 15%
Debt to Equity
-
Low
Low ≥ 1
High ≤ 0.3
* Institutions hold a combined 0.00% of the total shares of Verici Dx Plc
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
—
EPS Estimate
—
Date
2025-06-30
EPS Actual
-0.02
EPS Estimate
0
EPS Difference
-0.02
Surprise Percent
0%
(Last Updated 2025-06-30)
(Last Updated 2025-06-30)
Revenue
£ 0
Cost Of Revenue
£ 0
Gross Profit
£ 0
Operating Expenses
£ 0
Operating Income
£ 0
Interest Expense
£ 0
Pretax Income
£ 0
Net Income
£ 0
Income Tax Expense
£ 0
EBITDA
£ 0
Total Other Income Expense Net
£ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2025-06-30)
Cash
£ 0
Short Term Investments
£ 0
Receivables
£ 0
Inventories
£ 0
Total Current Assets
£ 0
Property Plant Equipment
£ 0
Total Assets
£ 0
Payables
£ 0
Short Term Debt
£ 0
Long Term Debt
£ 0
Total Liabilities
£ 0
Equity
£ 0
(Last Updated 2025-06-30)
Net Income
£ 0
Depreciation
£ 0
Change In Working Capital
£ 0
Cash From Operations
£ 0
Capital Expenditures
£ 0
Cash From Investing
£ 0
Cash From Financing
£ 0
Net Change In Cash
£ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.